Back

Real-world evidence for patient phenotypes in heart failure with preserved ejection fraction

31 August 2024 (18:00 - 18:50)
Organised by: Logo
Congress Presentation Part of: Heart failure therapy: new insights Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Thomas Mondritzki

Bayer AG, Wuppertal (Germany)

7 More presentations in this session

Presentation thumbnail
Treatment with flozins across the whole spectrum of heart failure in Poland between February 2022 and June 2023 based on Heart Failure Observational Study by Polish Cardiac Society..
Doctor R. Morawiec (Lodz, PL)
Abstract Slides Video
Presentation thumbnail
Feasibility and efficacy of acetazolamide in the treatment of acute decompensated heart failure
Doctor Y. Iemura (Kawagoe, JP)
Abstract Slides Video
Presentation thumbnail
Efficacy of acetazolamide as adjunct therapy in improving fluid management in patients with acute congestive heart failure: a systematic review and meta-analysis of randomized controlled trials
Doctor I. Tolentino Narciso (Montes Claros, BR)
Abstract Slides Video
Presentation thumbnail
The efficacy of IV iron in anemic heart failure patients: a systemic review and meta-analysis of randomised controlled trials.
Doctor A. Al Qurm (JO)
Abstract Slides Video
Presentation thumbnail
Effects of anakinra on patients with heart failure below and above 60 years of age
Doctor M. Golino (Jacksonville, US)
Abstract Slides Video

Access the full session

Session thumbnail
Heart failure therapy: new insights

The Event

Event poster

ESC Congress 2024

31 August 2024 18:00 CET
You may be interested in
thumbnail
Congress Presentation
Phenogrouping HFpEF trajectories identifies early and end-stage subtypes: a multicentre study using natural language processing
thumbnail
Congress Presentation
Mortality-based clustering reveals distinct subgroups in heart failure with preserved ejection fraction
thumbnail
Congress Presentation
Phenotyping in heart failure with reduced ejection fraction - A cluster analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources